Subcutaneous Drug Delivery Devices Market Scope
Subcutaneous Drug Delivery Devices refer to tools that are made for the delivery of a drug or therapeutic agent via the specific route of administration. Such devices are used as a part of one or more medical treatments. These devices help in increasing the efficiency of drug delivery system by controlling dosage, time, and place of release of the drugs in the body. The rising demand for subcutaneous drug delivery is attributed to the rapid development of biologics. Moreover, the subcutaneous route of administration is generally preferred, as it enables self-medication, improves the quality of life, and thus reduces healthcare costs. The market for subcutaneous drug delivery devices is increasing due to the rising accessibility and affordability of the drug delivery devices, whereas strict regulatory requirements for approval of subcutaneous drug delivery devices may hinder the market growth.
The Subcutaneous Drug Delivery Devices market study is segmented by Type (Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors and Needle-free Injectors) and major geographies with country level break-up.
The global Subcutaneous Drug Delivery Devices market including many local as well as regional players. Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Subcutaneous Drug Delivery Devices market throughout the predicted period.
Gerresheimer AG (Germany), Medtronic Plc (United States), Ypsomed AG (Switzerland), Elcam Medical Group (Israel), Novo Nordisk (Denmark), Insulet Corporation (United States), Becton, Dickinson and Company (United States), West Pharmaceutical Services, Inc. (United States), Sanofi. (France) and PharmaJet (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Unilife Corporation (United States) and Inolife Sciences (Canada).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Subcutaneous Drug Delivery Devices market by Type, Application and Region.
On the basis of geography, the market of Subcutaneous Drug Delivery Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
in March 2018, Sanofi S.A. announced the U.S. FDA approval for its maximum unit injection pen - Toujeo Max SoloStar. The device is designed to accommodate a volume of 900 units/mL. The device will help in reducing injection numbers and thus lower medical spending.
- Increasing product innovations and approvals
- Rising prevalence of chronic diseases
- Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
- Improving economic conditions in the region
- Rising geriatric population, technological advancements, and increasing demand for improved subcutaneousdrug delivery systems
- High cost of advanced delivery systems
- Strict regulatory requirements for approval of subcutaneous drug delivery devices
- Problems related to the use of drug delivery devices such as dosage error
Key Target AudienceSubcutaneous Drug Delivery Devices Industry Investors, Subcutaneous Drug Delivery Devices Providers/Vendors, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Research Institutes, Original Equipment Manufacturer, Component Supplier, Distributors, Government Body & Associations and End-user
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase